Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Muna R. Mian"'
Autor:
Muna R. Mian, Gbeminiyi Samuel, Oghale O. Asagbra, Shiva Poola, Eslam Ali, Josef Kinderwater, MaryKate Kratzer, Karissa Lambert, Jennifer Udom
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related deaths in the United States. Still, 1 in 3 adults aged 50 years to 75 years have not been screened for CRC. Early detection and manageme
Autor:
Muna R. Mian, Stephanie O. Page, Doyle M. Cummings, Shivajirao P. Patil, Jarrod Uhrig, James R. Powell, Kerry Sewell, Basem M. Mishriky
Publikováno v:
The Journal of Clinical Pharmacology. 60:980-991
Our aim was to explore whether the baseline hemoglobin A1c or the dose of sodium glucose cotransporter-2 inhibitor (SGLT-2i) chosen better predicted the efficacy of SGLT-2i versus dipeptidyl peptidase-4 inhibitor (DPP-4i) in type 2 diabetes. We searc
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-4 (2021)
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-4 (2021)
Background We report a rare case of a patient who presented with chest pain and was found to have a constellation of rare cardiac anomalies. Case presentation A 67-year-old patient with no past medical history presented with chest pain. He had mild t
Autor:
Jarrod L, Uhrig, Stephanie O, Page, Basem M, Mishriky, Shivajirao P, Patil, James R, Powell, Kerry, Sewell, Muna R, Mian, Doyle M, Cummings
Publikováno v:
Journal of clinical pharmacologyReferences. 60(8)
Our aim was to explore whether the baseline hemoglobin A
Publikováno v:
Diabetes. 68
Diabetes remains one of the most common chronic conditions seen in primary care clinics. While it remains one of the toughest quality measures to fulfill, it is crucial since we are approaching “Pay for Performance” in healthcare that will determ
Autor:
Kerry Sewell, James R. Powell, Jarrod Uhrig, Doyle M. Cummings, Stephanie O. Page, Basem M. Mishriky, Muna R. Mian
Publikováno v:
Diabetes. 68
Both sodium glucose cotransporter 2 inhibitors (SGLT2i) and dipeptidyl peptidase 4 inhibitors (DPP-4i) are effective drugs known to reduce hemoglobin A1c (A1c). While some guidelines favor SGLT2i over DPP-4i, there is no clear criteria in choosing be
Autor:
Josef Kinderwater, Jennifer Udom, Cphq, MaryKate Kratzer, Karissa Lambert, Elijah E. Asagbra, Eslam O. Ali, Muna R. Mian, Shiva Poola, Gbeminiyi Samuel
Publikováno v:
American Journal of Gastroenterology. 115:S155-S155